An Investigator And Subject Blinded, Sponsor Open, Randomized, Placebo Controlled, Multiple Dose Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of Pf-05089771 In Healthy Subjects And In Subjects With Osteoarthritis Of The Knee.
Phase of Trial: Phase I
Latest Information Update: 11 Dec 2012
At a glance
- Drugs PF 5089771 (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 11 Dec 2012 Actual initiation date changed from Dec 2011 to Jan 2012 as reported by ClinicalTrials.gov.
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Sep 2012 Planned end date changed from 1 Aug 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.